BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 19404955)

  • 1. Important role of interleukin-3 in the early phase of collagen-induced arthritis.
    Brühl H; Cihak J; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Goebel N; Plachý J; Stangassinger M; Mack M
    Arthritis Rheum; 2009 May; 60(5):1352-61. PubMed ID: 19404955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
    Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
    Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
    Sarkar S; Tesmer LA; Hindnavis V; Endres JL; Fox DA
    Arthritis Rheum; 2007 Jan; 56(1):89-100. PubMed ID: 17195211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library.
    Lee SI; Hyun PM; Kim SH; Kim KS; Lee SK; Kim BS; Maeng PJ; Lim JS
    Arthritis Rheum; 2005 Jan; 52(1):345-53. PubMed ID: 15641090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An early sympathetic nervous system influence exacerbates collagen-induced arthritis via CD4+CD25+ cells.
    Härle P; Pongratz G; Albrecht J; Tarner IH; Straub RH
    Arthritis Rheum; 2008 Aug; 58(8):2347-55. PubMed ID: 18668589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of Gr-1+,CCR2+ monocytes in collagen-induced arthritis.
    Brühl H; Cihak J; Plachý J; Kunz-Schughart L; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Luckow B; Stangassinger M; Mack M
    Arthritis Rheum; 2007 Sep; 56(9):2975-85. PubMed ID: 17763443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
    Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
    Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of IL-12 in early and late stages of murine collagen type II arthritis.
    Joosten LA; Lubberts E; Helsen MM; van den Berg WB
    J Immunol; 1997 Oct; 159(8):4094-102. PubMed ID: 9379000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis.
    Hasselberg A; Schön K; Tarkowski A; Lycke N
    Arthritis Rheum; 2009 Jun; 60(6):1672-82. PubMed ID: 19479868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
    Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.
    Srinivasan M; Eri R; Zunt SL; Summerlin DJ; Brand DD; Blum JS
    Arthritis Rheum; 2007 Feb; 56(2):498-508. PubMed ID: 17265485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gamma delta T cells in murine collagen-induced arthritis.
    Peterman GM; Spencer C; Sperling AI; Bluestone JA
    J Immunol; 1993 Dec; 151(11):6546-58. PubMed ID: 8245484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
    Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
    Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
    Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
    Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17.
    Yoshihara K; Yamada H; Hori A; Yajima T; Kubo C; Yoshikai Y
    Eur J Immunol; 2007 Oct; 37(10):2744-52. PubMed ID: 17823984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.